The COVID-19 pandemic is challenging the world in unprecedented ways, especially for patients who have a variety of other chronic diseases, including obesity.
In the editorial, the editors discuss the connection between COVID-19 and obesity and point out how people are at higher risk for severe complications from COVID-19 by virtue of the increased risk of the chronic diseases that obesity drives.
In addition, they note that obesity can also make it more difficult to treat respiratory complications in an intensive care unit setting.
Older age and co-morbid disease have been reported as risk factors for death while the present European experience seems to indicate more and more severe cases among younger age groups.
People with obesity around the world are already at high risk for severe complications of COVID-19. According to a study published on February 15, 2020, “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China” states that the prevalence of diabetes was 20% and of hypertension 30% in the first cases analyzed for risk factors for severe disease.
While China does not have the high incidence of obesity as that in the US when obesity is defined by BMI, China has been experiencing an epidemic of type 2 diabetes, with prevalence rates similar to the US.